<< Surprises found In gene variation associated with schizophrenia | Sorority members were urged to lie about their health >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

New and Generic Drug Approvals from FDA

Published on April 12, 2004 at 2:06 PM · No Comments
New and Generic Drug Approvals
  • Abilify (aripiprazole) Tablets, Otsuka
  • Celexa (citalopram hydrobromide) Tablets & Oral Solution, Forest Laboratories
  • Effexor & Effexor XR (Venlafaxine Hydrochloride) Immediate & Extended Release Tablets & Capsules,Wyeth Pharmaceuticals
  • Human Secretion Injection, ChiRhoClin, Inc.
  • Lexapro (escitalopram oxalate) Tablets & Oral Solution, Forest Pharmaceuticals
  • Nasacort AQ (triamcinolone acetonide) Nasal Aerosol, Aventis Pharmaceuticals
  • Paxil (paroxetine HCl) Imm ediate-Release & Controlled-Release Tablets, GlaxoSmithKline
  • Ritalin LA (methylphenidate hydrochloride) ER Capsules, Novartis Pharmaceuticals
  • Sodium Chloride Irrigation Solution, Abbott Laboratories
  • Sotalol Hydrochloride Tablets (AF), Mutual Pharmaceutical
  • Sterile Water for Injection, USP, Abbott Laboratories
  • Vigamox (moxifloxacin hydrochloride) Ophthalmic Solution, Alcon, Inc.
  • Loratadine Syrup, Novex Pharma, Tentative Approval

Posted in: Pharmaceutical News

Tags: , , , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading